Testing changes in jawbone problems in adults
Part of Bones, joints & muscles, Mouth & dental clinical trials.
This study looks at what changes happen in the jawbone in people with osteonecrosis of the jaw (a damaged jawbone area), whether or not they take certain cancer/bone medicines. It may help doctors better understand the condition and how it behaves over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years of age or older
- You can be taking anti-bone/anti-cancer treatment (ART) or not
- You can have osteonecrosis of the jaw (MRONJ) or not
- Do not smoke more than 10 cigarettes per day
- You must not be pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how bone quality changes over time in patients with medication-related osteonecrosis of the jaw (MRONJ), a condition where jaw bone fails to heal after certain medications. By comparing repeated CT scans, researchers hope to better understand the condition and improve care.
This study looks at how a specific jaw problem (osteonecrosis) may happen in people taking bone-strengthening medications. It aims to better understand and manage this side effect.
This study compares two surgical techniques (one using a special ultrasonic tool, the other using conventional instruments) for treating early stages of a jaw bone condition called MRONJ, which can be caused by certain medications. The goal is to see which approach is safer and more effective, so participants are randomly assigned to one of the two methods.
This trial tests whether a special dressing made from your own blood (called L-PRF) can help your jaw heal better after surgery for medication-related bone damage. It's for people who need surgery for this condition and aims to improve recovery.
This trial uses a special imaging technique called radiomics to check how well your jawbone heals after a tooth is removed and the socket is preserved. It may help doctors predict bone quality for future dental implants.
This study looks at people taking bone-strengthening drugs (like bisphosphonates or denosumab) who need dental work, such as tooth extraction or root canals. It aims to reduce the rare risk of jaw bone damage (osteonecrosis of the jaw) and help dentists and doctors choose the best timing for procedures.
Hear when a new Osteonecrosis of the Jaw trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.